Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nod

A Loxo Oncology Inc drug shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation won U.S. approval on Monday, according to the Food and Drug Administration's website.

from Reuters: Health News https://ift.tt/2P45E1M
via IFTTT